Lilly Wins Ruling Delaying Teva Bid To Market Generic EvistaCNNMoney.comWASHINGTON -(Dow Jones)- A federal appeals court on Tuesday upheld a trial judge's decision to delay Teva Pharmaceutical Industries Ltd.'s (TEVA) bid to market a generic version of Eli Lilly & Co.'s (LLY) blockbuster osteoporosis drug Evista. …Fed. Circ. Affirms Stay Extension In Evista Dispute IP [...]

Earnings Trends Highlights: Bristol-Myers Squibb Co., Merck & Co …Zacks.com, ILAmong the stocks in the sector that reported very strong year over year gains in EPS as well as very large positive earning surprises were some of the major drug firms like Bristol-Myers Squibb Co. (BMY), Merck & Co. (MRK) and Schering-Plough …Zacks Earnings Trends [...]

Straits Times

Wyeth: Its infant formula not to blame in ChinaThe Associated PressTRENTON, NJ (AP) — Drugmaker Wyeth, a top player in China's infant formula market, is dismissing claims its products are to blame in the latest round of reports there linking nutrition products to kidney stones in infants. Wyeth said Tuesday its …More claims of [...]

SYS-CON Media

Abbott completes Advanced Medical tender offerForbes, NYAP , 02.25.09, 10:25 AM EST Medical products and drug maker Abbott Laboratories said Wednesday it completed its tender offer for Advanced Medical Optics Inc. and will close the .36 billion buyout soon. On Jan. 12, Abbott said it would buy the Santa …Abbottt completes tender offer for eye-surgery [...]

Reuters

Sanofi-Aventis touts success of Zentiva offerInternational Herald Tribune, FranceAP PARIS: Sanofi-Aventis SA said its long-running effort to take over Czech pharmaceutical firm Zentiva NV was completed Wednesday, a deal it says will make it the world's 11th-largest generic drug manufacturer. Paris-based Sanofi-Aventis said …Sanofi-aventis Announces Success of Zentiva Offer The FINANCIALSanofi-Aventis Says Zentiva Takeover Successful, Holds [...]

The Merck Company Foundation Launches Five-Year Effort to Close …PR Newswire (press release), NY25 /PRNewswire-USNewswire/ — The Merck Company Foundation (Foundation), the philanthropic arm of Merck & Co., Inc., today announced the launch of The Alliance to Reduce Disparities in Diabetes (Alliance), a new initiative designed to improve …Merck launches million diabetes outreach program Medical [...]

Novartis's Currency Headache: Lost In TranslationForbes, NYNovartis had a rocky morning on Wednesday, after the Swiss company, which reports its results in US dollars, said a recent strengthening of the greenback would have a negative impact on its first-quarter results. Shares of Novartis (nyse: NVS - news …Novartis Down On Warning Dollar Strength Hurting 1Q EasyBourse.comUDPATE [...]

Deals with AstraZeneca, GlaxoSmithKline boost PozenBizjournals.com, NCRevenue jumped, to 66.1 million, from .4 million, as the company brought in .8 million more from the AstraZeneca agreement and .4 million in royalties from GlaxoSmithKline (NYSE: GSK) on sales of the migraine drug Treximet. …Pozen 4Q loss narrows on partnership payments ForbesPozen posts narrower-than-expected Q4 loss ReutersPOZEN Reports [...]

People's Pharmacy: Some drug companies are facing heatHouston Chronicle, United StatesOther pharmaceutical firms that have had to pay huge fines for misconduct include Schering-Plough, Bayer, Merck, Abbott and AstraZeneca. In an industry that is supposed to be putting patients first, it seems that executives are sometimes willing to …

AFP

Fibromyalgia Medication Scrapped by PfizerAssociated Content, COAsbury Park Press (APP.com) has posted a report on the drug giant Pfizer. I have a personal interest in this report. According to the article "Pfizer kills fibromyalgia, anxiety drugs" Pfizer has found profit to be the better part of valor. …Pfizer axes two drug development programs MarketWatchPfizer Drops Two [...]